Blueprint Medicines Corp Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Blueprint Medicines Corp quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Blueprint Medicines Corp Current Ratio for the quarter ending June 30, 2024 was 382 %, a 32.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 382 -187 -32.8% Jun 30, 2024
Q1 2024 407 -191 -32% Mar 31, 2024
Q4 2023 441 -157 -26.2% Dec 31, 2023
Q3 2023 494 -57.1 -10.4% Sep 30, 2023
Q2 2023 569 +44.5 +8.47% Jun 30, 2023
Q1 2023 598 +87.1 +17% Mar 31, 2023
Q4 2022 598 +13 +2.21% Dec 31, 2022
Q3 2022 551 -133 -19.5% Sep 30, 2022
Q2 2022 525 -188 -26.4% Jun 30, 2022
Q1 2022 511 -204 -28.5% Mar 31, 2022
Q4 2021 585 -99.8 -14.6% Dec 31, 2021
Q3 2021 684 +57.7 +9.2% Sep 30, 2021
Q2 2021 713 +142 +25% Jun 30, 2021
Q1 2021 714 +97.2 +15.8% Mar 31, 2021
Q4 2020 685 +88.1 +14.8% Dec 31, 2020
Q3 2020 627 -56.1 -8.21% Sep 30, 2020
Q2 2020 570 -231 -28.8% Jun 30, 2020
Q1 2020 617 -295 -32.4% Mar 31, 2020
Q4 2019 597 -516 -46.4% Dec 31, 2019
Q3 2019 683 -631 -48% Sep 30, 2019
Q2 2019 801 -577 -41.9% Jun 30, 2019
Q1 2019 912 -497 -35.2% Mar 31, 2019
Q4 2018 1.11K -149 -11.8% Dec 31, 2018
Q3 2018 1.31K +282 +27.4% Sep 30, 2018
Q2 2018 1.38K +459 +50% Jun 30, 2018
Q1 2018 1.41K +684 +94.2% Mar 31, 2018
Q4 2017 1.26K +539 +74.4% Dec 31, 2017
Q3 2017 1.03K +285 +38.2% Sep 30, 2017
Q2 2017 918 +97 +11.8% Jun 30, 2017
Q1 2017 725 -270 -27.1% Mar 31, 2017
Q4 2016 724 -191 -20.8% Dec 31, 2016
Q3 2016 746 -143 -16.1% Sep 30, 2016
Q2 2016 821 Jun 30, 2016
Q1 2016 995 Mar 31, 2016
Q4 2015 914 Dec 31, 2015
Q3 2015 890 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.